Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-03-04 Sale |
2025-03-06 4:10 pm |
Syndax Pharmaceuticals Inc | SNDX | Metzger Michael A Chief Executive Officer |
7,814 | $15.05 | $117,564 | 300,121 (Direct) |
View |
| 2025-02-10 Sale |
2025-02-12 5:16 pm |
Syndax Pharmaceuticals Inc | SNDX | Goldan Keith A. Chief Financial Officer |
3,777 | $15.5 | $58,559 | 90,746 (Direct) |
View |
| 2025-02-10 Sale |
2025-02-12 5:15 pm |
Syndax Pharmaceuticals Inc | SNDX | Metzger Michael A Chief Executive Officer |
13,288 | $15.5 | $206,017 | 300,121 (Direct) |
View |
| 2025-02-10 Sale |
2025-02-12 5:13 pm |
Syndax Pharmaceuticals Inc | SNDX | Gallagher Neil President, Head of R&D |
4,618 | $15.5 | $71,597 | 85,095 (Direct) |
View |
| 2024-06-14 Purchase |
2024-06-17 09:26 am |
Syndax Pharmaceuticals Inc | SNDX | Goldan Keith A. Chief Financial Officer |
1,250 | $20.03 | $25,037 | 52,623 (Direct) |
View |
| 2023-08-09 Sale |
2023-08-10 06:50 am |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Director |
52,855 | $18.27 | $965,402 | 17,836 (Direct) |
View |
| 2023-08-02 Sale |
2023-08-03 09:12 am |
Syndax Pharmaceuticals Inc | SNDX | Meury William Director |
83,000 | $20.46 | $1,697,810 | 48,000 (Direct) |
View |
| 2023-07-10 Sale |
2023-07-11 09:23 am |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Director |
52,855 | $20.4 | $1,078,068 | 17,836 (Direct) |
View |
| 2023-06-13 Sale |
2023-06-14 4:20 pm |
Syndax Pharmaceuticals Inc | SNDX | Goldan Keith A. Chief Financial Officer |
577 | $22.31 | $12,873 | 2,628 (Direct) |
View |
| 2023-06-09 Sale |
2023-06-09 5:32 pm |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Director |
52,855 | $21.18 | $1,119,421 | 17,836 (Direct) |
View |
| 2023-05-09 Sale |
2023-05-10 4:11 pm |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Director |
52,855 | $21.41 | $1,131,478 | 17,836 (Direct) |
View |
| 2023-04-10 Sale |
2023-04-12 4:03 pm |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Director |
52,855 | $19.53 | $1,032,237 | 17,836 (Direct) |
View |
| 2023-03-13 Sale |
2023-03-14 4:42 pm |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs President, Head of R&D |
52,854 | $22.53 | $1,190,674 | 17,836 (Direct) |
View |
| 2023-02-15 Sale |
2023-02-17 6:09 pm |
Syndax Pharmaceuticals Inc | SNDX | Ordentlich Peter Chief Scientific Officer |
25,000 | $25.84 | $646,093 | 0 (Direct) |
View |
| 2023-02-06 Sale |
2023-02-08 4:49 pm |
Syndax Pharmaceuticals Inc | SNDX | Metzger Michael A Chief Executive Officer |
5,959 | $27.64 | $164,697 | 17,659 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-14 Exercise |
2025-03-17 06:01 am |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Metzger Michael A Chief Executive Officer |
6,074 | $7.2 | 306,195 (Direct) |
View |
| 2025-03-14 Exercise |
2025-03-17 06:01 am |
N/A 2025-06-01 |
Syndax Pharmaceuticals Inc | SNDX | Metzger Michael A Chief Executive Officer |
6,074 | $0 | 306,195 (Direct) |
View |
| 2025-03-04 Exercise |
2025-03-06 4:10 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Metzger Michael A Chief Executive Officer |
7,814 | $7.2 | 300,121 (Direct) |
View |
| 2025-03-04 Exercise |
2025-03-06 4:10 pm |
N/A 2025-06-01 |
Syndax Pharmaceuticals Inc | SNDX | Metzger Michael A Chief Executive Officer |
7,814 | $0 | 300,121 (Direct) |
View |
| 2025-02-05 Option Award |
2025-02-07 4:45 pm |
N/A 2035-02-05 |
Syndax Pharmaceuticals Inc | SNDX | Gallagher Neil President, Head of R&D |
110,500 | $14.65 | 200,213 (Direct) |
View |
| 2025-02-05 Option Award |
2025-02-07 4:45 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Gallagher Neil President, Head of R&D |
41,900 | $0 | 200,213 (Direct) |
View |
| 2025-02-05 Option Award |
2025-02-07 4:44 pm |
N/A 2035-02-05 |
Syndax Pharmaceuticals Inc | SNDX | Goldan Keith A. Chief Financial Officer |
110,500 | $14.65 | 205,023 (Direct) |
View |
| 2025-02-05 Option Award |
2025-02-07 4:44 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Goldan Keith A. Chief Financial Officer |
41,900 | $0 | 205,023 (Direct) |
View |
| 2025-02-05 Option Award |
2025-02-07 4:42 pm |
N/A 2035-02-05 |
Syndax Pharmaceuticals Inc | SNDX | Metzger Michael A Chief Executive Officer |
364,000 | $14.65 | 677,409 (Direct) |
View |
| 2025-02-05 Option Award |
2025-02-07 4:42 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Metzger Michael A Chief Executive Officer |
149,500 | $0 | 677,409 (Direct) |
View |
| 2025-02-05 Option Award |
2025-02-07 4:41 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Podlesak Dennis Director |
50,000 | $0 | 191,763 (Direct) |
View |
| 2025-02-05 Option Award |
2025-02-07 4:39 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Rizo Aleksandra Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2025-02-05 Option Award |
2025-02-07 4:38 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Meury William Director |
25,000 | $0 | 90,000 (Direct) |
View |
| 2025-02-05 Option Award |
2025-02-07 4:37 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Katkin Keith Director |
25,000 | $0 | 90,000 (Direct) |
View |
| 2025-02-05 Option Award |
2025-02-07 4:35 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Jarrett Jennifer Director |
25,000 | $0 | 90,000 (Direct) |
View |
| 2025-02-05 Option Award |
2025-02-07 4:34 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Huber Martin H. Jr. Director |
25,000 | $0 | 74,000 (Direct) |
View |
| 2025-02-05 Option Award |
2025-02-07 4:32 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Legault Pierre Director |
25,000 | $0 | 90,000 (Direct) |
View |
| 2024-05-15 Option Award |
2024-05-16 4:04 pm |
N/A 2034-05-15 |
Syndax Pharmaceuticals Inc | SNDX | Rizo Aleksandra Director |
35,000 | $0 | 35,000 (Direct) |
View |
| 2024-02-07 Option Award |
2024-02-09 4:05 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Metzger Michael A Chief Executive Officer |
146,250 | $0 | 378,409 (Direct) |
View |
| 2024-02-07 Option Award |
2024-02-09 4:05 pm |
N/A 2034-02-07 |
Syndax Pharmaceuticals Inc | SNDX | Metzger Michael A Chief Executive Officer |
214,500 | $22.28 | 378,409 (Direct) |
View |
| 2023-07-31 Other |
2024-02-09 4:05 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Goldan Keith A. Chief Financial Officer |
862 | $18.12 | 123,418 (Direct) |
View |
| 2024-02-07 Option Award |
2024-02-09 4:05 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Goldan Keith A. Chief Financial Officer |
46,700 | $0 | 123,418 (Direct) |
View |
| 2024-01-31 Other |
2024-02-09 4:05 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Goldan Keith A. Chief Financial Officer |
1,183 | $17.42 | 123,418 (Direct) |
View |
| 2024-02-07 Option Award |
2024-02-09 4:05 pm |
N/A 2034-02-07 |
Syndax Pharmaceuticals Inc | SNDX | Goldan Keith A. Chief Financial Officer |
70,000 | $22.28 | 123,418 (Direct) |
View |
| 2024-02-07 Option Award |
2024-02-09 4:05 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Gallagher Neil President, Head of R&D |
47,813 | $0 | 117,188 (Direct) |
View |
| 2024-02-07 Option Award |
2024-02-09 4:05 pm |
N/A 2034-02-07 |
Syndax Pharmaceuticals Inc | SNDX | Gallagher Neil President, Head of R&D |
69,375 | $22.28 | 117,188 (Direct) |
View |
| 2024-02-07 Option Award |
2024-02-09 4:04 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Huber Martin H. Jr. Director |
17,000 | $0 | 49,000 (Direct) |
View |
| 2024-02-07 Option Award |
2024-02-09 4:04 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Jarrett Jennifer Director |
17,000 | $0 | 65,000 (Direct) |
View |
| 2024-02-07 Option Award |
2024-02-09 4:04 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Katkin Keith Director |
17,000 | $0 | 65,000 (Direct) |
View |
| 2024-02-07 Option Award |
2024-02-09 4:04 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Meury William Director |
17,000 | $0 | 65,000 (Direct) |
View |
| 2024-02-07 Option Award |
2024-02-09 4:04 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Director |
17,000 | $0 | 34,836 (Direct) |
View |
| 2024-02-07 Option Award |
2024-02-09 4:04 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Podlesak Dennis Director |
34,000 | $0 | 141,763 (Direct) |
View |
| 2024-02-07 Option Award |
2024-02-09 4:04 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Legault Pierre Director |
17,000 | $0 | 65,000 (Direct) |
View |
| 2023-08-09 Exercise |
2023-08-10 06:50 am |
2027-02-06 N/A |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Director |
52,855 | $0 | 17,836 (Direct) |
View |
| 2023-08-09 Exercise |
2023-08-10 06:50 am |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Director |
52,855 | $8.77 | 17,836 (Direct) |
View |
| 2023-08-02 Exercise |
2023-08-03 09:12 am |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Meury William Director |
35,000 | $7.11 | 48,000 (Direct) |
View |
| 2023-08-02 Exercise |
2023-08-03 09:12 am |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Meury William Director |
24,000 | $7.88 | 48,000 (Direct) |
View |
| 2023-08-02 Exercise |
2023-08-03 09:12 am |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Meury William Director |
24,000 | $9.47 | 48,000 (Direct) |
View |
| 2023-08-02 Exercise |
2023-08-03 09:12 am |
N/A 2030-02-12 |
Syndax Pharmaceuticals Inc | SNDX | Meury William Director |
83,000 | $0 | 48,000 (Direct) |
View |
| 2023-07-10 Exercise |
2023-07-11 09:23 am |
N/A 2027-02-06 |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Director |
52,855 | $0 | 17,836 (Direct) |
View |
| 2023-07-10 Exercise |
2023-07-11 09:23 am |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Director |
52,855 | $8.77 | 17,836 (Direct) |
View |
| 2023-06-09 Exercise |
2023-06-09 5:32 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Director |
24,582 | $6.38 | 17,836 (Direct) |
View |
| 2023-06-09 Exercise |
2023-06-09 5:32 pm |
N/A 2027-02-06 |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Director |
52,855 | $0 | 17,836 (Direct) |
View |
| 2023-06-09 Exercise |
2023-06-09 5:32 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Director |
28,273 | $8.77 | 17,836 (Direct) |
View |
| 2023-05-09 Exercise |
2023-05-10 4:11 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Director |
52,855 | $6.38 | 17,836 (Direct) |
View |
| 2023-05-09 Exercise |
2023-05-10 4:11 pm |
N/A 2029-02-06 |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Director |
52,855 | $0 | 17,836 (Direct) |
View |
| 2023-04-10 Exercise |
2023-04-12 4:03 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Director |
52,855 | $6.38 | 17,836 (Direct) |
View |
| 2023-04-10 Exercise |
2023-04-12 4:03 pm |
N/A 2029-02-06 |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Director |
52,855 | $0 | 17,836 (Direct) |
View |
| 2023-04-10 Option Award |
2023-04-12 4:02 pm |
N/A 2033-04-10 |
Syndax Pharmaceuticals Inc | SNDX | Gallagher Neil President, Head of R&D |
250,000 | $19.35 | 250,000 (Direct) |
View |
| 2023-03-13 Exercise |
2023-03-14 4:42 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs President, Head of R&D |
52,854 | $6.38 | 17,836 (Direct) |
View |
| 2023-03-13 Exercise |
2023-03-14 4:42 pm |
N/A 2029-02-06 |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs President, Head of R&D |
52,854 | $0 | 17,836 (Direct) |
View |
| 2023-02-15 Exercise |
2023-02-17 6:09 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Ordentlich Peter Chief Scientific Officer |
17,428 | $7.2 | 0 (Direct) |
View |
| 2023-02-15 Exercise |
2023-02-17 6:09 pm |
N/A 2025-06-01 |
Syndax Pharmaceuticals Inc | SNDX | Ordentlich Peter Chief Scientific Officer |
25,000 | $25.84 | 0 (Direct) |
View |
| 2023-02-15 Exercise |
2023-02-17 6:09 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Ordentlich Peter Chief Scientific Officer |
7,572 | $6.38 | 0 (Direct) |
View |
| 2023-02-06 Exercise |
2023-02-08 4:49 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Metzger Michael A Chief Executive Officer |
5,959 | $6.38 | 17,659 (Direct) |
View |
| 2023-02-06 Exercise |
2023-02-08 4:49 pm |
N/A 2029-02-06 |
Syndax Pharmaceuticals Inc | SNDX | Metzger Michael A Chief Executive Officer |
5,959 | $27.64 | 17,659 (Direct) |
View |